Canadian Diabetes Association Clinical Practice Guidelines Management of Stroke in Diabetes Chapter 27 Michael Sharma, Gord Gubitz.

Slides:



Advertisements
Similar presentations
The Essentials 5th Annual CE LHIN CME
Advertisements

Chapter 38 Stewart B. Harris, Onil Bhattacharyya,
Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Preventing Strokes One at a Time Acute Interventions and Management 2009.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
Canadian Diabetes Association Clinical Practice Guidelines Hyperglycemic Emergencies in Adults Chapter 15 Jeannette Goguen, Jeremy Gilbert.
Canadian Diabetes Association Clinical Practice Guidelines Hypoglycemia Chapter 14 Dale Clayton, Jean-François Yale, Vincent Woo.
Canadian Diabetes Assocation Clinical Practice Guidelines Pancreas and Islet Cell Transplant Chapter 20 Breay W. Paty, Angela Koh, Peter Senior.
Canadian Diabetes Association Clinical Practice Guidelines Pregnancy
Canadian Diabetes Association Clinical Practice Guidelines Weight Management in Diabetes Chapter 17 Sean Wharton, Arya M. Sharma, David C.W. Lau.
Aggressive Hyperglycemia Management. Significant hospital hyperglycemia requires close follow-up Previously diagnosed diabetes and elevated A1C Without.
Canadian Diabetes Association Clinical Practice Guidelines Natural Health Products in Type 2 Diabetes Chapter 21 Richard Nahas, Jeannette Goguen.
Canadian Diabetes Association Clinical Practice Guidelines Diabetes in the Elderly Chapter 37 Graydon S. Meneilly, Daniel Tessier, Aileen Knip.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.
Screening for Type 1 and Type 2 Diabetes Chapter 4 Jean-Marie Ekoé, Zubin Punthakee, Thomas Ransom, Ally PH Prebtani, Ron Goldenberg Canadian Diabetes.
Canadian Diabetes Association Clinical Practice Guidelines Chronic Kidney Disease in Diabetes Chapter 29 Phil McFarlane, Richard E. Gilbert, Lori MacCallum,
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Canadian Diabetes Association Clinical Practice Guidelines Monitoring for Glycemic Control Chapter 9 Lori Berard, Ian Blumer, Robyn Houlden, David Miller,
Diabetes and Mental Health Chapter 18 David J. Robinson, Meera Luthra, Michael Vallis Canadian Diabetes Association 2013 Clinical Practice Guidelines.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
BEDTIME INSULIN IN TYPE 2 DIABETES J. Robin Conway M.D. Diabetes Clinic, Smiths Falls,ON
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Canadian Diabetes Association Clinical Practice Guidelines Neuropathy Chapter 31 Vera Bril, Bruce Perkins, Cory Toth.
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
Canadian Diabetes Association 2013 Clinical Practice Guidelines Targets for Glycemic Control Chapter 8 S. Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross.
Canadian Diabetes Association Clinical Practice Guidelines Vascular Protection in People with Diabetes Chapter 22 James A. Stone, David Fitchett, Steven.
Canadian Diabetes Association Clinical Practice Guidelines Erectile Dysfunction Chapter 33 Gerald Brock, William Harper.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Reducing the Risk of Developing Diabetes Chapter 5 Thomas Ransom, Ronald Goldenberg, Amanda Mikalachki, Ally PH Prebtani, Zubin Punthakee Canadian Diabetes.
Quality of Care and Outcomes in Patients with Diabetes Hospitalized with Ischemic Stroke Findings From Get With The Guidelines-Stroke Reeves MJ; Vaidya.
Canadian Diabetes Association Clinical Practice Guidelines Physical Activity and Diabetes Chapter 10 Ronald J Sigal, Marni J Armstrong, Pam Colby, Glen.
Lookback Module: What you should know 2012 National Conference on Health Statistics Monitoring Health Care Reform through Provider-based Surveys: New Initiatives.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Translating Clinical Trials Into Clinical Practice Cliff Bailey on behalf of the Global Partnership for Effective Diabetes Management This slideset was.
Glycemic Control for myocardial infraction. Why??????
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.

Benefits of Urgent Evaluation and Treatment for TIA and Minor Stroke Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency.
Reducing the Risk of T2DM: What Works?
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Experience in Other Provinces: Nova Scotia Stroke System Neala Gill, RN, BN, MA Cardiovascular Health Nova Scotia Quebec Summit on Stroke October 7, 2008.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
Specialised Geriatric Services Heather Gilley Sharon Straus.
Achieving Glycemic Control in the Hospital Setting Part 1 of 3
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Screening. By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Angela Aziz Donnelly April 5, 2016
Optimal Blood Glucose Monitoring
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
The ADEMEX Trial Adequacy of PD in Mexico Reference
Figure 1. Consort flow diagram.
Diabetic Dyslipidemia in Practice
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
The Cardiologist's Mindset in the Management of Diabetes and Coronary Artery Disease: Today and Tomorrow.
Juan J. Russo et al. JACC 2019;73:
Reducing the Risk of Developing Diabetes
Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.
Glycemic control in Hispanic and non-Hispanic patients during the SWITCH 2 trial. Glycemic control in Hispanic and non-Hispanic patients during the SWITCH.
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

Canadian Diabetes Association Clinical Practice Guidelines Management of Stroke in Diabetes Chapter 27 Michael Sharma, Gord Gubitz

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association SCREEN for diabetes in all patients admitted with ischemic stroke or Transient Ischemic Attack (TIA) MANAGE in-hospital glycemia as one would for any other reason for admission TREAT the ischemic stroke or TIA in a patient with diabetes the same as a patient without diabetes, using Canadian Stroke Strategy Best Practices Recommendation Stroke in Diabetes Checklist

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Patients with DM are 2-3X More Likely to Have a Stroke Public Health Agency of Canada (August 2011); using 2008/09 data from the Canadian Chronic Disease Surveillance System (Public Health Agency of Canada).

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Idris I, et al. Int J Clin Pract 2006;60: People with Diabetes and Stroke Have Worse Outcomes Increased hospital and long-term mortality More residual neurologic disability More residual functional disability Longer hospital stays

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Bellolio MF, et al. Cochrane Database of Systematic Reviews 2011 Sep 7;(9):CD doi: / CD pub3. Treat Glycemia the Same as in Other Conditions Usually premeal BG 5-8 mmol/L, random <10 mmol/L Cochrane Systematic Review of 7 randomized controlled trials of intensive insulin therapy (target BG mmol/L) versus usual care in acute ischemic stroke showed no benefit in the outcomes of death, disability or dependence, and there was an increase in hypoglycemia

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 1.Patients with ischemic stroke or transient ischemic attack should be screened for diabetes with a fasting plasma glucose, A1C, or 75-g OGTT soon after admission to hospital [Grade D, Consensus] 2.All patients with diabetes and ischemic stroke or transient ischemic attack (TIA) should receive the same treatments that are recommended for patients with ischemic stroke or TIA without diabetes since they benefit equally [Grade D, Consensus] 2013 Recommendations 1 and 2

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CDA Clinical Practice Guidelines – for professionals BANTING ( ) – for patients